Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

M-Cdk Drives Transition Into Mitosis

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

Psychoneuroimmunology: Diabetes and Cancer

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Spontaneous renal artery dissection with renal artery stenting: A case report.

Urology case reports·2026

Same author

Development and validation of a model to predict the risk of frailty in older adults with panvascular disease.

Frontiers in public health·2025

Same author

Application of the Fifth-Generation Cardiac Contractility Modulation Device in a Patient with Chronic Heart Failure: A Case Report.

International medical case reports journal·2024

Same author

Nitroglycerin plus clopidogrel for acute myocardial infarction and the effect on cardiac function indices.

Pakistan journal of pharmaceutical sciences·2023

Same author

Expression and Clinical Significance of Serum sST2, BDNF, CTnI, and BUN/Cr in Patients With Heart Failure.

Alternative therapies in health and medicine·2022

Same author

A Review of Structural Features, Biological Functions and Biotransformation Studies in Adipose Tissues and an Assessment of Progress and Implications.

Endocrine, metabolic & immune disorders drug targets·2022

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)

Published on: April 19, 2013

Association between type 2 diabetes and CDKN2A/B: a meta-analysis study.

Xiao Yun Bao¹, Cui Xie, Mao Sheng Yang

¹Laboratory of Disorder Genes and Department of Pharmacology, College of Pharmacy, Chongqing Medical University, P.O. 380, 1 Yi Xue Yuan Road, Chongqing 400016, People's Republic of China.

Molecular Biology Reports

|June 1, 2011

Summary

This summary is machine-generated.

The rs10811661 T allele in the CDKN2A/B gene is linked to an increased risk of type 2 diabetes (T2D). This meta-analysis confirms the association, particularly in European and Asian populations, warranting further investigation.

Related Experiment Videos

Last Updated: Jun 1, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)

Published on: April 19, 2013

Area of Science:

Genetics
Endocrinology
Metabolic Diseases

Background:

The Cyclin-dependent kinase inhibitor-2A/B (CDKN2A/B) gene is implicated in type 2 diabetes (T2D) due to its role in pancreatic beta-cell function.
Previous studies on the association between CDKN2A/B and T2D have yielded inconsistent results.

Purpose of the Study:

To clarify the association between T2D and specific single nucleotide polymorphisms (SNPs) in the CDKN2A/B gene.
To conduct a meta-analysis on the prevalence of alleles and genotypes for rs10811661 and rs564398 in CDKN2A/B.

Main Methods:

Systematic review of PubMed, EMBASE, and Medline databases for studies published between January 2006 and November 2010.
Meta-analysis of 16 selected studies, comprising 24,407 T2D cases and 33,937 controls.
Statistical analysis of allele and genotype frequencies for rs10811661 and rs564398 within the CDKN2A/B gene.

Main Results:

The rs10811661 T allele (OR 1.28) and TT genotype (OR 1.32) in CDKN2A/B were significantly associated with an increased risk of T2D.
No significant association was found for rs564398 in CDKN2A/B with T2D.
The association of the rs10811661 T allele with T2D was consistent across Asian and European ethnic groups.

Conclusions:

The rs10811661 variant in the CDKN2A/B gene is a risk factor for type 2 diabetes.
Further large-scale studies involving diverse ethnicities are needed to validate these findings.